FDA Clears DxNA's H1N1 Test for Emergency Use | GenomeWeb

NEW YORK (GenomeWeb News) – Genetic test developer DxNA said today that the US Food and Drug Administration has granted Emergency Use Authorization (EUA) for the firm's PCR-based test for 2009 H1N1 influenza.

The EUA for DxNA's GeneSTAT detection platform is a legal means that allows FDA to authorize new medical devices during medical emergencies.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: role for epigenetic in neuronal excitability, and more.

The new Office of Research Integrity director is grappling with complaints from her staff, according to ScienceInsider.

Italian researchers link SNPs in the PDSS2 gene to coffee consumption in a new paper.

A gene-editing ban has been interpreted to include mitochondrial transfer, Technology Review reports.